tiprankstipranks
Advertisement
Advertisement
Click Therapeutics Highlights Positive Phase III Data for CT-132 Migraine Therapeutic
PremiumPrivate CompaniesClick Therapeutics Highlights Positive Phase III Data for CT-132 Migraine Therapeutic
10d ago
Click Therapeutics Positions Over-the-Counter Digital Therapeutics as New Growth Avenue
Premium
Private Companies
Click Therapeutics Positions Over-the-Counter Digital Therapeutics as New Growth Avenue
12d ago
Click Therapeutics Highlights Over-the-Counter Digital Therapeutics Strategy at FT Summit
Premium
Private Companies
Click Therapeutics Highlights Over-the-Counter Digital Therapeutics Strategy at FT Summit
12d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100